These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 35304514)
1. MiR-206 conjugated gold nanoparticle based targeted therapy in breast cancer cells. Chaudhari R; Nasra S; Meghani N; Kumar A Sci Rep; 2022 Mar; 12(1):4713. PubMed ID: 35304514 [TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer. Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of miR-155 in MCF-7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer. Kardani A; Yaghoobi H; Alibakhshi A; Khatami M J Cell Physiol; 2020 Oct; 235(10):6887-6895. PubMed ID: 32003016 [TBL] [Abstract][Full Text] [Related]
4. Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells. Yu X; Zhang X; Dhakal IB; Beggs M; Kadlubar S; Luo D BMC Cancer; 2012 Jan; 12():29. PubMed ID: 22260523 [TBL] [Abstract][Full Text] [Related]
5. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration. Salem O; Erdem N; Jung J; Münstermann E; Wörner A; Wilhelm H; Wiemann S; Körner C BMC Genomics; 2016 Aug; 17():566. PubMed ID: 27502506 [TBL] [Abstract][Full Text] [Related]
6. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells. Zhong S; Li W; Chen Z; Xu J; Zhao J Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196 [TBL] [Abstract][Full Text] [Related]
8. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage. Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369 [TBL] [Abstract][Full Text] [Related]
9. Gold nanoparticle-based 2'-O-methyl modified DNA probes for breast cancerous theranostics. Li J; Huang J; Yang X; Yang Y; Quan K; Xie N; Wu Y; Ma C; Wang K Talanta; 2018 Jun; 183():11-17. PubMed ID: 29567152 [TBL] [Abstract][Full Text] [Related]
10. MiRNA-138-5p: A strong tumor suppressor targeting PD-L-1 inhibits proliferation and motility of breast cancer cells and induces apoptosis. Rasoolnezhad M; Safaralizadeh R; Hosseinpourfeizi MA; Banan-Khojasteh SM; Baradaran B Eur J Pharmacol; 2021 Apr; 896():173933. PubMed ID: 33545160 [TBL] [Abstract][Full Text] [Related]
11. Designing a gold nanoparticle-based nanocarrier for microRNA transfection into the prostate and breast cancer cells. Ekin A; Karatas OF; Culha M; Ozen M J Gene Med; 2014; 16(11-12):331-5. PubMed ID: 25331590 [TBL] [Abstract][Full Text] [Related]
12. Dysregulated miR-183 inhibits migration in breast cancer cells. Lowery AJ; Miller N; Dwyer RM; Kerin MJ BMC Cancer; 2010 Sep; 10():502. PubMed ID: 20858276 [TBL] [Abstract][Full Text] [Related]
13. miRNA expression patterns in chemoresistant breast cancer tissues. Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164 [TBL] [Abstract][Full Text] [Related]
14. MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line. Boo L; Ho WY; Ali NM; Yeap SK; Ky H; Chan KG; Yin WF; Satharasinghe DA; Liew WC; Tan SW; Ong HK; Cheong SK Int J Biol Sci; 2016; 12(4):427-45. PubMed ID: 27019627 [TBL] [Abstract][Full Text] [Related]
15. High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth. Leivonen SK; Sahlberg KK; Mäkelä R; Due EU; Kallioniemi O; Børresen-Dale AL; Perälä M Mol Oncol; 2014 Feb; 8(1):93-104. PubMed ID: 24148764 [TBL] [Abstract][Full Text] [Related]
16. MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers? Cizeron-Clairac G; Lallemand F; Vacher S; Lidereau R; Bieche I; Callens C BMC Cancer; 2015 Jul; 15():499. PubMed ID: 26141719 [TBL] [Abstract][Full Text] [Related]
17. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression. Mansoori B; Mohammadi A; Ghasabi M; Shirjang S; Dehghan R; Montazeri V; Holmskov U; Kazemi T; Duijf P; Gjerstorff M; Baradaran B J Cell Physiol; 2019 Jun; 234(6):9816-9825. PubMed ID: 30480817 [TBL] [Abstract][Full Text] [Related]
18. miR-641 Inhibited Cell Proliferation and Induced Apoptosis by Targeting NUCKS1/PI3K/AKT Signaling Pathway in Breast Cancer. Li L; Wei D; Zhang J; Deng R; Tang J; Su D Comput Math Methods Med; 2022; 2022():5203839. PubMed ID: 35069784 [TBL] [Abstract][Full Text] [Related]
19. Aidi injection alters the expression profiles of microRNAs in human breast cancer cells. Zhang H; Zhou QM; Lu YY; Du J; Su SB J Tradit Chin Med; 2011 Mar; 31(1):10-6. PubMed ID: 21563499 [TBL] [Abstract][Full Text] [Related]
20. Reconstruction of temporal activity of microRNAs from gene expression data in breast cancer cell line. Jayavelu ND; Bar N BMC Genomics; 2015 Dec; 16():1077. PubMed ID: 26763900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]